Primary sclerosing cholangitis

Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that primarily affects the bile ducts. It is characterized by the inflammation and progressive scarring (fibrosis) of the bile ducts, which can lead to the narrowing and eventual blockage of these ducts. The bile ducts are responsible for carrying bile, a substance produced by the liver to help digest fats, from the liver to the small intestine.

As the bile ducts become damaged and obstructed, bile can build up in the liver, causing liver damage and leading to cirrhosis (scarring of the liver). Over time, PSC can lead to liver failure.

Key Features of Primary Sclerosing Cholangitis:

1. Chronic Inflammation and Scarring: PSC causes chronic inflammation and scarring in the bile ducts. As the ducts become more damaged, they may become narrowed or blocked, preventing bile from flowing properly.
2. Symptoms: In the early stages, PSC may not cause noticeable symptoms, but as the disease progresses, it can cause a variety of symptoms, including:
   • Fatigue (tiredness and lack of energy).
   • Itching (pruritus), often severe.
   • Jaundice (yellowing of the skin and eyes) due to the buildup of bilirubin, a substance in bile.
   • Abdominal pain (especially in the upper right abdomen).
   • Weight loss and loss of appetite.
   • Dark urine and pale stools.
3. Liver Complications: As PSC progresses, it can lead to cirrhosis, liver failure, and an increased risk of developing liver cancer (hepatocellular carcinoma).
4. Bile Duct Damage: PSC specifically targets the bile ducts, causing strictures (narrowing), bile duct dilation, and eventually scarring. This damage impairs the ability of bile to flow properly, causing a buildup in the liver.
5. Association with Inflammatory Bowel Disease (IBD): PSC is strongly associated with inflammatory bowel disease (IBD), particularly ulcerative colitis. Most individuals with PSC also have IBD, although not all do.

Causes and Risk Factors:

The exact cause of PSC is not fully understood, but it is believed to be an autoimmune disorder, where the body's immune system mistakenly attacks the bile ducts. Several factors contribute to the development of PSC:

• Genetic predisposition: A family history of PSC or autoimmune diseases may increase the risk.
• Autoimmune factors: The immune system's attack on the bile ducts suggests an autoimmune mechanism.
• Inflammatory bowel disease (IBD): A significant proportion of people with PSC also have IBD, particularly ulcerative colitis.

Diagnosis:

Diagnosis of PSC is typically based on a combination of clinical symptoms, medical history, imaging tests, and laboratory tests:

1. Blood tests: Liver function tests (such as elevated liver enzymes) and tests for specific autoimmune markers.
2. Imaging: Magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP) are commonly used to visualize the bile ducts and identify abnormalities like strictures, dilation, or blockages.
3. Liver biopsy: In some cases, a liver biopsy may be performed to assess the degree of liver damage or cirrhosis.

Treatment:

There is currently no cure for PSC, but treatment aims to manage symptoms, slow disease progression, and address complications. Treatment options include:

• Medications:
  • Ursodeoxycholic acid (UDCA) may be prescribed to help improve bile flow and protect the liver, although its effectiveness in PSC is debated.
  • Immunosuppressive drugs may be used in some cases, especially if the patient has autoimmune features.
  • Steroids: For flare-ups or symptoms related to associated inflammatory bowel disease.
• Liver transplantation: If liver failure occurs, a liver transplant may be necessary, particularly if cirrhosis develops or if the patient develops liver cancer.
• Symptomatic treatment: Treatments for symptoms like itching (e.g., antihistamines, cholestyramine) and vitamin supplementation (since bile helps absorb fat-soluble vitamins like A, D, E, and K) may be recommended.

Prognosis:

PSC is a progressive disease, meaning it typically worsens over time. However, the rate of progression can vary greatly between individuals. Some people may live for many years with manageable symptoms, while others may progress to liver failure more quickly. The disease is often monitored with regular imaging and blood tests to assess liver function and bile duct health.

The liver transplant offers the best potential for long-term survival in individuals with advanced PSC, particularly if cirrhosis or liver cancer develops. However, PSC can sometimes recur in the transplanted liver, though this is less common.

‍